Axon Enterprise vs. Kratos: Which Defense & Security Stock has Greater Upside?

Axon Enterprise (AXON) and Kratos Defense & Security Solutions (KTOS), prominent aerospace and defense equipment providers, exhibit distinct financial dynamics. Axon reported robust Q1 2025 revenue growth in Connected Devices (+26.1%) and Software & Services (+39%) driven by product innovation and strategic partnerships, yet faces significant margin pressure from escalating costs, notably a 48% increase in SG&A, and trades at a high 109.34x forward P/E. Conversely, Kratos secured substantial government contracts, including a record $1.45 billion hypersonic test bed award, contributing to a $1.51 billion backlog, and despite supply chain concerns, offers a more attractive 74.74x forward P/E. The analysis suggests Kratos is a more compelling investment due to its strong contract pipeline, stable funding, and favorable valuation relative to Axon's cost challenges and premium.

Analysis

Axon Enterprise (AXON) and Kratos Defense & Security Solutions (KTOS) are both capitalizing on expansionary U.S. budgetary policy and heightened security needs, but exhibit divergent fundamental profiles. Axon demonstrates robust top-line momentum, with its Connected Devices segment growing 26.1% and its Software & Services segment increasing 39% year-over-year in Q1 2025, driven by new products like the TASER 10 and a strategic drone partnership with Skydio. However, this growth is significantly challenged by escalating operational costs, evidenced by a 48% surge in SG&A expenses, which pressures margins and contributes to a high forward P/E ratio of 109.34X. In contrast, Kratos has secured substantial government-backed order flow, highlighted by a record $1.45 billion hypersonic contract and multiple drone-related awards, culminating in a robust $1.51 billion backlog. This backlog provides strong revenue visibility, with 48% expected to be recognized in 2025. Despite facing potential supply-chain disruptions, Kratos's stock has significantly outperformed Axon's over the past six months (+61.7% vs. +23.2%), and it trades at a more favorable forward P/E of 74.74X, supported by stable 2025 and upwardly revised 2026 EPS estimates.

Key Decisions for Investors

• Given its substantial $1.51 billion contract backlog, upwardly trending 2026 earnings estimates, and a more favorable valuation, Kratos (KTOS) currently presents a more compelling investment case relative to Axon.
• Investors in Axon (AXON) should closely monitor margin performance, as the 48% year-over-year increase in SG&A expenses poses a significant risk to profitability that could challenge its premium 109.34x forward P/E valuation.
• For Kratos, the primary focus should be on its execution capabilities, specifically its ability to convert its large backlog into revenue as projected and mitigate the stated supply-chain risks which could impact its top-line performance.